Regulatory B cells in mouse models of intestinal inflammation

Methods in Molecular Biology

Volumn 1190, Issue , 2014, Pages 227-241

  Nishida, Atsushi ^a,b   Lau, Cindy W ^a,b   Mizoguchi, Emiko ^a,b   Mizoguchi, Atsushi ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breg; Gut associated lymphoid tissues (GALT); IL 10; Inflammatory bowel disease (IBD); Lamina propria lymphocyte

Indexed keywords

DEXTRAN SULFATE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL CULTURE; B LYMPHOCYTE; CELL ISOLATION; ENRICHMENT CULTURE; ENTERITIS; EXPERIMENTAL COLITIS; IMMUNOPHENOTYPING; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LYMPHOCYTE FUNCTION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL SEPARATION; CHEMICALLY INDUCED; COLITIS; COLON; CULTURE TECHNIQUE; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOID TISSUE; PATHOLOGY; PROCEDURES;

ANIMALS; B-LYMPHOCYTES, REGULATORY; CELL CULTURE TECHNIQUES; CELL SEPARATION; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL;

EID: 84924083246     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1161-5_16     Document Type: Article

References (37)

1. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434
2. Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573-621
3. Talley NJ, Abreu MT, Achkar JP et al (2011) American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 106:S2-S25
4. Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54
5. Targan SR, Karp LC (2005) Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 206:296-305
6. Mombaerts P, Mizoguchi E, Grusby MJ et al (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274-282
7. Ma A, Datta M, Margosian E et al (1995) T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 182:1567-1572
8. Mizoguchi A, Mizoguchi E, Smith RN et al (1997) Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 186:1749-1756
9. Wei B, Velazquez P, Turovskaya O et al (2005) Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA 102:2010-2015
10. Ray A, Basu S, Williams CB et al (2012) A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 188:3188-3198
11. Moritoki Y, Lian ZX, Lindor K et al (2009) B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 50:1893-1903
12. Gerth AJ, Lin L, Neurath MF et al (2004) An innate cell-mediated, murine ulcerative colitislike syndrome in the absence of nuclear factor of activated T cells. Gastroenterology 126:1115-1121
13. Shinzaki S, Iijima H, Fujii H et al (2012) Altered oligosaccharide structures reduce colitis induction in mice defective in β-1, 4-galactosyl transferase. Gastroenterology 142: 1172-1182
14. Kirkland D, Benson A, Mirpuri J et al (2012) B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36: 228-238
15. Mizoguchi A, Mizoguchi E, Takedatsu H et al (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16:219-230
16. Sugimoto K, Ogawa A, Shimomura Y et al (2007) Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133:124-136
17. Mizoguchi E, Mizoguchi A, Preffer FI et al (2000) Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 12:597-605
18. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176:705-710
19. Schmidt EG, Larsen HL, Kristensen NN et al (2012) B cells exposed to enterobacterial components suppress development of experimental colitis. Inflamm Bowel Dis 18:284-293
20. Yanaba K, Yoshizaki A, Asano Y et al (2011) IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 178:735-743
21. Dass S, Vital EM, Emery P (2007) Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 56:2715-2718
22. Tayal V, Chiu YH, George E et al (2011) Colitis associated with active systemiclupus erythematosus successfully treated with rituximab. J Clin Rheumatol 17:79-82
23. Leiper K, Martin K, Ellis A et al (2011) Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 60:1520-1526
24. Goetz M, Atreya R, Ghalibafian M, et al (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13: 1365-1368
25. El Fassi D, Nielsen CH, Junker P et al (2011) Systemic adverse events following rituximab therapy in patients with Graves' disease. J Endocrinol Invest 34:e163-e167
26. Ardelean DS, Gonska T, Wires S et al (2010) Severe ulcerative colitis after rituximab therapy. Pediatrics 126:e243-e246
27. Bhalme M, Hayes S, Norton A et al (2013) Rituximab-associated colitis. Inflamm Bowel Dis 19:E41-E43
28. Sekkach Y, Hammi S, Elqatni M et al (2011) Ulcerative colitis: exceptional consequence after rituximab therapy. Ann Pharm Fr 69:265-269
29. Nishida A, Nagahama K, Imaeda H et al (2012) Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4 + T cells. J Exp Med 209:2383-2394
30. Bouabe H (2012) Cytokine reporter mice: the special case of IL-10. Scand J Immunol 75:553-567
31. Madan R, Demircik F, Surianarayanan S et al (2009) Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 183:2312-2320
32. Mizoguchi A (2012) Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 105:263-320
33. Mishima Y, Ishihara S, Aziz MM et al (2010) Decreased production of interleukin-10 and transforming growth factor-beta in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice. Immunology 131:473-487
34. Shimomura Y, Mizoguchi E, Sugimoto K et al (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20:729-737
35. Shimomura Y, Ogawa A, Kawada M et al (2008) A unique B2 B cell subset in the intestine. J Exp Med 205:1343-1355
36. Mauri C, Bosma A (2012) Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241
37. Mackay F, Figgett WA, Saulep D et al (2010) B-cell stage and context-dependent requirements for survival signals from BAFF and the B-cell receptor. Immunol Rev 237:205-225